MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Predictive factors for a favorable STN-DBS outcome in Parkinson’s Disease: the role of axial symptoms

    C. Ledda, C. Artusi, G. Imbalzano, M. Bozzali, M. Rizzone, A. Romagnolo, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: We sought to identify and weight clinical and demographic factors predicting bilateral STN-DBS outcomes. Background: DBS is an established therapeutic option for treating PD…
  • 2022 International Congress

    Relationship between falls and motor state in Parkinson’s disease patients with motor fluctuations

    Y. Okuma (Izunokuni, Japan)

    Objective: To elucidate in which motor state Parkinson’s disease (PD) patients with motor fluctuations fall. Background: Recurrent falls are a disabling feature of PD and…
  • 2022 International Congress

    The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.

    M. Boyce, A. Mccambridge, L. Bradnam, C. Canning, A. Verhagen (Ultimo, Australia)

    Objective: This systematic review aimed to determine the barriers to satisfaction and facilitators that could improve satisfaction with BoNT therapy for people with CD. Background:…
  • 2022 International Congress

    In vivo synaptic density in parkinsonism

    C. Uribe, KL. Desmond, R. Raymond, K. Smart, A. Reilhac, A. Mena, AE. Lang, G. Kovacs, N. Vasdev, AP. Strafella (Toronto, Canada)

    Objective: To provide first evidence of in vivo binding properties of the [18F]SynVesT-1 tracer (aka [18F]-SDM-8) for the quantification of synaptic density loss in a…
  • 2022 International Congress

    Exploring Young people’s role in providing relief to grandparents affected with Alzheimer

    M. Busgopaul (Port Louis, Mauritius)

    Objective: In some families, children never know that their parents or grandparents are affected by the Parkinson’s Disease (PD). Whatever be the way that Movement…
  • 2022 International Congress

    ADOPTION Study: Status update of a Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This study aims to evaluate the effect of once-daily opicapone (OPC) 50 mg versus an additional dose of levodopa (L-dopa)/dopa decarboxylase inhibitor (DDCi) to…
  • 2022 International Congress

    Hemichorea secondary to Middle Cerebral Artery (MCA) Stenosis without evidence of ischemic stroke in the basal ganglia

    M. Bruno (Honolulu, USA)

    Objective: To describe two patients who presented with hemichorea from isolated MCA stenosis without evidence of basal ganglia stroke. Background: Hyperkinetic movement disorders can occur…
  • 2022 International Congress

    Response of freezing, posture and voice to increasing levodopa doses in Parkinson’s disease

    G. Imbalzano, D. Rinaldi, G. Calandra Buonaura, M. Contin, F. Amato, G. Giannini, L. Sambati, C. Ledda, A. Romagnolo, G. Olmo, P. Cortelli, M. Zibetti, C. Artusi, L. Lopiano (Torino, Italy)

    Objective: To analyze the resistance to high levodopa doses of FoG, posture, speech, and gait features in PD patients during a daily-ON therapeutic condition. Background:…
  • 2022 International Congress

    Theta-burst Cycling for Deep Brain Stimulation

    J. Maclean, J. Olaya, M. Liker, T. Sanger (Orange, USA)

    Objective: To test the clinical efficacy of rapid-cycling deep brain stimulation (DBS) in children and young adults with dystonia. Background: Cycling of DBS for variable…
  • 2022 International Congress

    Cognitive-motor tests markedly increase the diagnostic rate of “On-meds” freezing of gait in Parkinson’s disease during clinical visits

    Z. Pei (Guangzhou, China)

    Objective: To develop a testing and recording system that can reliably increase the rate of diagnosing freezing of gait (FOG) in patients living with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley